27-Feb-2026
Download PDF
Zydus Lifesciences
Zydus Lifesciences announces successful clinical development of Pembrolizumab biosimilar FYB206 marking a milestone toward USFDA filing.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
